Search

Cytophage Technologies announced on August 25, 2025 that it received two Letters of No Objection from Health Canada's Food Directorate for its OvaPhage egg-surface and PhageFend food-surface bacteriophage products. According to the company,

Feature on the Reference Center for Complex Osteoarticular Infections (CrioaC) at Croix-Rousse Hospital in Lyon, where Professor Tristan Ferry's team treats patients at a therapeutic impasse with phages, a treatment the service has pioneere

University of Waterloo School of Pharmacy researchers use a modified version of the M13 bacteriophage to deliver chosen therapeutic genes to specific human cells, with no unwanted virus or bacteria, as a cheaper and more efficient route to

In a Form 8-K dated August 19, 2025, BiomX reported that the FDA placed a clinical hold on its Phase 2b study of BX004 in cystic fibrosis while it reviews data on a third-party nebulizer used to deliver BX004. The FDA raised no concerns abo

Bemidji State University senior Bill Ketola, working in Dr Holly LaFerriere's lab, isolated a previously uncatalogued phage from a soil sample and named it Jant. It is lytic against Mycobacterium smegmatis, a safe lab bacterium that shares

Doctors at SHRI Hospital in Guntur, led by Dr K. Kalyan Chakravarthy with Prof. Gopal Nath of Banaras Hindu University, used bacteriophage therapy to treat a 72-year-old woman with a chronic multidrug-resistant Acinetobacter baumannii bone

iNtRON Biotechnology announced on August 5, 2025 that its IMPA (Intelligent Modular Phage Assembly) phage engineering technology produced a phage carrying a colibactin-degrading protein on its capsid. The company says the engineered phage k

On 4 August 2025 ASST Fatebenefratelli Sacco announced that its infectious diseases department had started phage therapy for a patient with a pressure ulcer infected by antibiotic-resistant Pseudomonas aeruginosa, described as one of the fi

Harvard Undergraduate Microbiology Society explainer by Srikara Tadigotla on phage-antibiotic synergy (PAS), which pairs inexpensive antibiotics with adaptable phages so that bacteria must trade off phage resistance against antibiotic resis

NASA's July 15, 2025 research preview for the SpaceX Crew-11 mission lists Genes in Space-12, a student-designed DNA experiment that examines the effects of microgravity on interactions between certain bacteria and bacteriophages, among inv

The University of Florida has granted Phageolytix an exclusive worldwide license to multi-indication bacteriophage cocktails developed by researchers in its College of Medicine-Jacksonville (announced July 14, 2025). Phageolytix will manufa

Dr. Stephen Vaughan (University of Calgary) successfully treated 76-year-old Boyd English's decade-long antibiotic-resistant hip infection using phage therapy. This is the first PJI phage treatment in Western Canada.

A Chinese University of Hong Kong team led by Professor Mao Chuanbin built engineered bacteriophages carrying a tumour-targeting peptide, platinum nanozymes that turn hydrogen peroxide into oxygen inside tumours, and the light-activated dru

Harvard Undergraduate Microbiology Society article by Ishaan Vitthala on “programmable” phages that deliver genetic circuits to reprogram bacteria rather than only kill them, with possible uses in the gut microbiome, agriculture, wastewater

The Phage Collection Project says its work was featured in the BBC article “I found a bacteria-eating virus in my loo — could it save your life?” www.phage-collection.org

Ruby Darwin, a PhD student in the University of Liverpool's Department of Infection Biology and Microbiomes, attended the two-day Targeting Phage Therapy 2025 conference virtually with IVES small grant funds. She highlights a first clinical

SNIPR Biome announced on June 12, 2025 that the first patient has been dosed in its Phase 1b study of SNIPR001, an orally administered CRISPR-armed phage therapeutic that targets E. coli in the gut, in hematological cancer patients undergoi

A team of authors from Israel and Portugal, including researchers from the Hadassah Medical Organization, tested the bacteriophage mixture TP-102 on 19 diabetic patients with infected and non-infected foot ulcers. TP-102 was safe and well t

Navy Medicine Research & Development reports that, over a six-year Congressionally Directed Medical Research Programs (CDMRP) award starting in fiscal year 2019, the Naval Medical Research Command worked with the U.S. Naval Research Laborat

On 4 June 2025 the UK Medicines and Healthcare products Regulatory Agency (MHRA) published the UK's first official guidance to support the safe development and use of phage therapies, covering both combined phage products for common infecti